We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Soligenix Inc | NASDAQ:SNGX | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.0177 | 4.42% | 0.4185 | 0.3999 | 0.4188 | 0.4186 | 0.39 | 0.404 | 147,619 | 00:07:51 |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported):
Commission File No.
(Exact name of small business issuer as specified in its charter)
| ||
(State or other jurisdiction of |
| (I.R.S. Employer |
|
|
|
| ||
(Address of principal executive offices) |
| (Zip Code) |
(
(Issuer’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
| Trading Symbol(s) |
| Name of each exchange on which registered |
|
| The |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
w
Item 5.07. Submission of Matters to a Vote of Security Holders.
As previously reported, Soligenix, Inc. (the “Company”) initially convened its 2023 Annual Meeting of Stockholders (the “Meeting”). As there was not a sufficient number of shares of the Company’s common stock present or represented by proxy in order to a constitute quorum, the Company adjourned the initial session of the Meeting on September 21, 2023 and the reconvened sessions of the Meeting on October 18, 2023 and November 16, 2023, without transaction any business.
On December 15, 2023, the Meeting reconvened. There being a sufficient number of shares of the Company’s common stock present or represented by proxy in order to a constitute quorum, the following items were voted upon:
Proposal One | Election of Directors: |
The following five nominees were elected as directors to serve until the 2024 Annual Meeting of Stockholders by votes as follows:
Name |
| For |
|
| Withheld |
| ||
Christopher J. Schaber, PhD | 2,392,737 | 1,519,856 | ||||||
Gregg A. Lapointe, CPA, MBA | 2,648,262 | 1,264,331 | ||||||
Diane L. Parks, MBA |
|
| 2,622,353 | 1,290,240 |
| |||
Robert J. Rubin, MD |
|
| 2,408,798 | 1,503,795 |
| |||
Jerome B. Zeldis, MD, PhD |
|
| 2,404,068 | 1,508,525 |
|
There were 1,602,901 broker non-votes in the election of directors.
Proposal Two | Non-binding advisory vote on executive compensation: |
The proposal to approve, by a non-binding advisory vote, the compensation of the Company’s named executive officers as disclosed in the Company’s 2023 proxy statement was approved, and the votes were as follows:
For |
| Against |
| Abstain |
2,315,274 |
| 707,529 |
| 889,790 |
There were 1,602,901 broker non-votes on this proposal.
Proposal Three | Ratification of the Appointment of Independent Registered Public Accounting Firm: |
The proposal to ratify the appointment of Cherry Bekaert LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2023 was approved by votes as follows:
For |
| Against |
| Abstain |
4,439,358 |
| 188,624 |
| 887,512 |
There were no broker non-votes on this proposal.
Item 9.01.Financial Statements and Exhibits.
(d) Exhibits.
Exhibit No. |
| Description |
104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Soligenix, Inc. | |
December 15, 2023 | By: | /s/ Christopher J. Schaber |
|
| Christopher J. Schaber, Ph.D. |
President and Chief Executive Officer | ||
(Principal Executive Officer) |
3
Document and Entity Information |
Dec. 15, 2023 |
---|---|
Document and Entity Information [Abstract] | |
Document Type | 8-K |
Document Period End Date | Dec. 15, 2023 |
Entity File Number | 001-14778 |
Entity Registrant Name | Soligenix, Inc. |
Entity Incorporation, State or Country Code | DE |
Entity Tax Identification Number | 41-1505029 |
Entity Address, Address Line One | 29 Emmons Drive |
Entity Address, Adress Line Two | Suite B-10 |
Entity Address, City or Town | Princeton |
Entity Address, State or Province | NJ |
Entity Address, Postal Zip Code | 08540 |
City Area Code | 609 |
Local Phone Number | 538-8200 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common Stock, par value $.001 per share |
Trading Symbol | SNGX |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | false |
Entity Central Index Key | 0000812796 |
Amendment Flag | false |
1 Year Soligenix Chart |
1 Month Soligenix Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions